This inventor holds 1 USPTO granted patent. Top assignee: Elite Pharma Technology (Shanghai) Co., Ltd.. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Qing Tian - Innovator in Pharmaceutical Technology
Introduction
Qing Tian is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of pharmaceutical technology, particularly in the development of innovative drug delivery systems. His work focuses on improving the efficacy and safety of medications through advanced formulation techniques.
Latest Patents
Qing Tian holds a patent for a metformin hydrochloride osmotic pump tablet and its preparation method. This invention provides a controlled-release mechanism for metformin hydrochloride, enhancing its therapeutic effects. The preparation method involves using a hetero-type stamping-prepared metformin hydrochloride tablet core, which is then coated with a controlled-release layer. This innovative approach allows for a more effective management of diabetes through improved drug delivery.
Career Highlights
Qing Tian is currently employed at Elite Pharma Technology (Shanghai) Co., Ltd. His role at the company involves research and development of pharmaceutical formulations. His expertise in osmotic pump technology has positioned him as a key player in the advancement of drug delivery systems.
Collaborations
Qing Tian collaborates with several professionals in his field, including Jianping Jiang and Wu Tian. These partnerships enhance the research and development efforts at Elite Pharma Technology, fostering innovation and improving product outcomes.
Conclusion
Qing Tian's contributions to pharmaceutical technology, particularly through his patented metformin hydrochloride osmotic pump tablet, demonstrate his commitment to advancing healthcare solutions. His work continues to impact the field positively, paving the way for more effective treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile